| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 4,176.20× | 4,176.20× | 7,342.89× | 7,548.93× | 5,264.29× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 162.30× | 162.30× | 220.54× | 278.51× | 231.64× | ||
| 243.70× | 243.70× | 230.58× | 278.88× | 476.84× | ||
| 4,094.80× | 4,094.80× | 7,332.85× | 7,548.56× | 5,019.09× | ||
| 0.58× | 0.26× | 0.19× | 0.32× | −15.45× | ||
| 0.11× | 0.11× | 0.08× | 0.05× | 0.07× | ||
| 1.14× | 1.14× | −12.63× | −1.86× | −0.18× | ||
| 1.22× | 1.22× | −4.99× | −1.57× | −0.08× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Inventory Days (DIO) | 5,264.29 | 7,548.93 | 7,342.89 | 4,176.20 | 4,176.20 | |
| Receivable Days (DSO) | 231.64 | 278.51 | 220.54 | 162.30 | 162.30 | |
| Payable Days (DPO) | 476.84 | 278.88 | 230.58 | 243.70 | 243.70 | |
| Cash Conversion Cycle (days) | 5,019.09 | 7,548.56 | 7,332.85 | 4,094.80 | 4,094.80 | |
| Working Capital Turnover | -15.45 | 0.32 | 0.19 | 0.26 | 0.58 | |
| Asset Turnover | 0.07 | 0.05 | 0.08 | 0.11 | 0.11 | |
| Cash Conversion (CFO/Net Income) | -0.18 | -1.86 | -12.63 | 1.14 | 1.14 | |
| CFO/EBITDA | -0.08 | -1.57 | -4.99 | 1.22 | 1.22 |